CATALENT
927210517ActiveGlobal CDMO accelerating drug development, manufacturing, and delivery solutions.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- Tuntematon
- Perustettu
Avainpäättäjät
Laura Hortas
Vice President, Corporate Communications
Charles Patten
Board Member
Charles Lickfold
Senior Vice President & Chief Technology Officer
John Greisch
Chairman of the Board
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Catalent is a premier global Contract Development and Manufacturing Organization (CDMO) dedicated to accelerating the development, manufacturing, and delivery of life-improving products. They partner extensively with pharmaceutical, biotechnology, and self-care companies worldwide to transform innov...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Norskregistrert utenlandsk foretak
- ALV-numero
- Tuntematon
Päättäjät
19 yhteystietoa FunnelfeedrissäLaura Hortas
Vice President, Corporate Communications
Charles Patten
Board Member
Charles Lickfold
Senior Vice President & Chief Technology Officer
John Greisch
Chairman of the Board
Marie-France Tschudin
Board Member
Scott Gunther
Senior Vice President, Quality & Regulatory Affairs
Sue Mahony
Board Member
Larry Anderson
Senior Group Leader, Analytical Development
Tim Walbert
Board Member
David McErlane
Group President, Biologics
Matti Masanovich
Senior Vice President & Chief Financial Officer
Susan Mahony
Board Director
Lisa Evoli
Senior Vice President & Chief Human Resources Officer
Ricky Hopson
Group President, Clinical and Specialty Services and Chief of Staff
Tom Hawkeswood
Senior Vice President, Global Operations
Jonathan Levy
Board Member
Alessandro Maselli
President & Chief Executive Officer
Aris Gennadios, Ph.D.
Group President, Pharma and Consumer Health
Joseph A. Ferraro
Senior Vice President, General Counsel, Chief Compliance Officer and Secretary
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
CAMBREX KARLSKOGA AKTIEBOLAG
500–999 työntekijätGlobal CDMO providing end-to-end drug development and manufacturing services.
Bioglan AB
100–199 työntekijätBioglan develops and manufactures semi-solids for pharma clients.
AGILERA PHARMA AS
136 työntekijätLeading CDMO realizing tomorrow's cancer medicine via radiopharmaceuticals.
NANOFORM FINLAND OY
1–4 työntekijätNanoforming technology enhances drug performance across development stages.
NEXTPHARMA GERMANY BIDCO GMBH
Leading European CDMO providing full pharmaceutical development and manufacturing services.
Selaa lisää
Kysymyksiä yrityksestä CATALENT
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo